Remember
 
 
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
     
 

Tuesday, May 2, 2017

SpeculatingStocks.com Stock Pick



Stock Price: $9.66

Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics.

VRX is the stock that Bill Ackman's Pershing Square pulled the plug on with various reports of a $2.8 - $4 billion loss. VRX really took a hit after high generic drug prices came under fire and around the same time Citron Research said Valeant could be the Pharmaceutical Enron. It has been all downhill since for VRX.


VRX is just starting to build back some momentum and announced trimming its debt on 5/1/17 by $3.6 billion. VRX trades at a market cap of $3.36 billion with $542 million in cash on its balance sheet. This company can get its act back together and with so many investors following it, there's reason to believe it can string together an uptrend from its current point.

Speculative Score: 4

1 Being the Least Speculative and Most Confident

10 Being the Most Speculative and Possibly the Most Risky

 
     
Untitled Document